Activity of ceftazidime/avibactam against problem Enterobacteriaceae and Pseudomonas aeruginosa in the UK, 2015

Activity of ceftazidime/avibactam against problem Enterobacteriaceae and Pseudomonas aeruginosa in the UK, 2015–16

Published:2017-12-08 Issue:3 Volume:73 Page:648-657
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Livermore David M¹²,Meunier Danièle¹^ORCID,Hopkins Katie L¹,Doumith Michel¹,Hill Robert¹,Pike Rachel¹,Staves Peter¹,Woodford Neil¹

Affiliation:

1. Antimicrobial Resistance and Healthcare Associated Infections (AMRHAI) Reference Unit, National Infection Service, Public Health England, London, UK

2. Norwich Medical School, University of East Anglia, Norwich, Norfolk, UK

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/73/3/648/23823640/dkx438.pdf

Reference32 articles.

1. The β-lactams strike back: ceftazidime-avibactam;Zasowski;Pharmacotherapy,2015

2. New β-lactam-β-lactamase inhibitor combinations in clinical development;Shlaes;Ann NY Acad Sci,2013

3. Kinetics of avibactam inhibition against Class A, C, and D β-lactamases;Ehmann;J Biol Chem,2013

4. Structural basis for different substrate profiles of two closely related Class D β-lactamases and their inhibition by halogens;Stojanoski;Biochemistry,2015

5. Activities of NXL104 combinations with ceftazidime and aztreonam against carbapenemase-producing Enterobacteriaceae;Livermore;Antimicrob Agents Chemother,2011

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PAM-1: an antimicrobial peptide with promise against ceftazidime-avibactam resistant Escherichia coli infection;Frontiers in Microbiology;2024-04-30

2. Performance of two immunochromatographic tests in detecting KPC variants conferring resistance to ceftazidime-avibactam;European Journal of Clinical Microbiology & Infectious Diseases;2024-04-15

3. A review of the mechanisms that confer antibiotic resistance in pathotypes of E. coli;Frontiers in Cellular and Infection Microbiology;2024-04-04

4. Activity of aztreonam/avibactam and ceftazidime/avibactam against Enterobacterales with carbapenemase-independent carbapenem resistance;International Journal of Antimicrobial Agents;2024-03

5. Extensively drug-resistant Pseudomonas aeruginosa: clinical features and treatment with ceftazidime/avibactam and ceftolozane/tazobactam in a tertiary care university hospital center in Portugal – A cross-sectional and retrospective observational study;Frontiers in Microbiology;2024-02-13